Sunday, December 22, 2024 | 06:41 PM ISTEN Hindi

Home / Companies / News / Serum Institute to invest $68 mn in UK vaccine-maker Oxford Biomedica

Serum Institute to invest $68 mn in UK vaccine-maker Oxford Biomedica

British cell therapy firm makes announcement.

Premium

Adar Poonawalla, CEO, Serum Institute of India

Reuters Bengaluru

1 min read Last Updated : Sep 22 2021 | 12:38 PM IST

Vaccine producer Serum Institute of India will invest 50 million pounds ($68.24 million) in Oxford Biomedica, one of the Covid-19 vaccine manufacturers for drug major AstraZeneca, the British cell therapy firm said on Wednesday.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Topics : Serum Institute AstraZeneca Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in